Evan Lockwood Rachlin Insider Trades & Stock Holdings

Director · Iambic Therapeutics, Inc. · Latest filing Oct 16, 2026

Evan Lockwood Rachlin, Director at Iambic Therapeutics, Inc. has 1 Form 4 trade on file since Oct 16, 2026. Open-market activity: 1 purchase ($11.50M) and 0 sales ($0), net +$11.50M. Latest filing: acquired 718.75K shares of $IAM on Oct 16, 2026 at $16.

Trades on file

1

Open-market bought

$11.50M

Open-market sold

$0

Net open-market

+$11.50M

Shares held ($IAM)

2.59M

Latest filing

Oct 16, 2026

Shares held by Evan Lockwood Rachlin

• $IAM2.59M sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Evan Lockwood Rachlin

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 16, 2026	$IAM	Buy (Open-market buy)	718.75K	$16	$11.50M	2.59M	+38.45%				Director	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Evan Lockwood Rachlin traded

• $IAM

Frequently asked questions

Has Evan Lockwood Rachlin been buying or selling stock?

Evan Lockwood Rachlin has 1 open-market purchase and 0 open-market sales on file, net +$11.50M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Evan Lockwood Rachlin's latest insider trade?

acquired 718.75K shares of $IAM on Oct 16, 2026 at $16.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.